Template:Warning/MDPV: Difference between revisions
>David Hedlund m |
>David Hedlund m |
||
Line 3: | Line 3: | ||
| content=Due to its unusually long duration, extreme potency, and compulsive nature, it is strongly discouraged to abuse this substance in high doses, multiple days in a row, or in combination with other drugs known to increase the risk of psychosis. MDPV was a common designer drug sold as "bath salt" both in the US and in Europe; The European Union (EU) reported 99 MDPV-related deaths between September 2009 and August 2013.<ref name="EMCDDA" /> | | content=Due to its unusually long duration, extreme potency, and compulsive nature, it is strongly discouraged to abuse this substance in high doses, multiple days in a row, or in combination with other drugs known to increase the risk of psychosis. MDPV was a common designer drug sold as "bath salt" both in the US and in Europe; The European Union (EU) reported 99 MDPV-related deaths between September 2009 and August 2013.<ref name="EMCDDA" /> | ||
<p> | |||
Please see [[MDPV #Toxicity and harm potential|this section]] for more details. | Please see [[MDPV #Toxicity and harm potential|this section]] for more details. | ||
</p> | |||
}}<noinclude>[[Category:Panels]]</noinclude> | }}<noinclude>[[Category:Panels]]</noinclude> |